BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2496 related articles for article (PubMed ID: 16252185)

  • 21. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
    Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
    Lamouliatte H; Cayla R; Zerbib F; Forestier S; de Mascarel A; Joubert-Collin M; Mégraud F
    Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
    Deltenre M; Jonas C; van Gossum M; Buset M; Otero J; De Koster E
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S39-44. PubMed ID: 8574734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
    Yang JC; Yang KC; Hsu CT; Wang CS; Kuo CF; Wang TH
    J Microbiol Immunol Infect; 1999 Mar; 32(1):1-8. PubMed ID: 11561564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
    Maconi G; Parente F; Russo A; Vago L; Imbesi V; Bianchi Porro G
    Am J Gastroenterol; 2001 Feb; 96(2):359-66. PubMed ID: 11232676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
    Multiple Center Study Group In Beijing Area, China
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1161-5. PubMed ID: 15387976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
    Laine L; Suchower L; Frantz J; Connors A; Neil G
    Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
    Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
    Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 125.